HEALTH

Reckitt Benckiser talks about Mucinex, Airborne line extensions

BY Michael Johnsen

SLOUGH, England — Reckitt Benckiser has line extended its Mucinex franchise into the year-round allergy sector with Mucinex Allergy, Heather Allen, Reckitt Benckiser EVP category development, told analysts Wednesday. 

"Super fantastic launch in the U.S.," she said. "Allergy is a $2.5 billion market in the U.S. More than 75% of Mucinex users also take an allergy treatment, and now, we’re able to offer them Mucinex Allergy, maximum strength, non-drowsy antihistamine, acts fast and lasts for 24 hours."

Reckitt Benckiser is also line extending its Airborne platform with Airborne Everyday. "People take it when they feel they need a boost or they feel they need support for their immune system," Allen explained. "We’re launching now Airborne Everyday, bringing immune support plus a multivitamin, because lots of Airborne users also take a multivitamin," she said. "Given we’ve had this business for about a year, we’re really, really excited to be driving all of this innovation to market."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

NAD recommends Trinity Sports Group discontinue certain claims for ‘NeuroImpact’

BY Michael Johnsen

NEW YORK — The National Advertising Division has recommended that Trinity Sports Group discontinue certain claims for the company’s “NeuroImpact” dietary supplement, including claims that the product has been clinically tested.

NAD noted, however, that the advertiser provided a reasonable basis for “carefully qualified ingredient claims regarding the ability of certain ingredients,” in NeuroImpact “to support healthy brain function.”

TSG explained that NeuroImpact contains a patent-pending blend of vitamins, supplements and herbs that it markets to athletes who participate in contact sports to support brain recovery. TSG argued that, in addition to following medical recommendations for concussion recovery  — including brain rest from video gaming, texting and active engagement — NeuroImpact can be used as a nutritional supplement to support brain recovery.

Following its review of the evidence in the record, NAD determined that because many of the ingredients in NeuroImpact are well-researched and understood to support the health or functioning of the brain, “it is possible that TSG could make limited claims about the role of its ingredients in supporting healthy brain function.”

NAD cautioned the advertiser, however, that advertising claims should match the strength of the research supporting them. In general, claims that are based on emerging research of ingredients in a product should indicate that the claims are based on research on the ingredients, and that the research is emerging and limited in their advertising claims.

Regarding the advertiser’s testimonials, NAD noted that it has “routinely held that an advertiser may not make claims through consumer testimonials that could not be substantiated if made independently by the advertiser, and that anecdotal evidence based solely on the experiences of individual consumers is insufficient to support product efficacy claims.”

In this case, NAD noted, the advertiser didn’t provide a reasonable basis for its efficacy claims and, as a result couldn’t support the claims made in its testimonials. NAD recommended that the testimonials be discontinued.

In its advertiser’s statement, Trinity Sports Group said that while it disagreed with NAD’s conclusions, “in the spirit of self-regulation, we will take NAD’s recommendations into account in future advertising.”

NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.

As part of its ongoing monitoring program and in conjunction with NAD’s initiative with the Council for Responsible Nutrition to expand the review of advertising claims for dietary supplements, NAD opened an inquiry into claims that were made by TSC.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Carma Labs partners with Zendaya on Carmex Moisture Plus line

BY Michael Johnsen

MILWAUKEE — Carma Laboratories on Wednesday announced its partnership with singer and actress Zendaya, whose self-titled album launched last fall featuring the hit single "Replay." Zendaya will serve as a spokesmodel for Carmex brand’s recently re-launched Carmex Moisture Plus line of fashionable lip balm. 

"We are thrilled to partner with Zendaya," Paul Woelbing, president of Carma Laboratories said. "She is one of the most popular young stars in music and television, and she has quickly become a style icon in her own right. She embodies the fashionable, fun user that we had in mind when we created our stylish Carmex Moisture Plus lip balm line."

"I use Carmex every day, so I’m excited to work with the brand on its new Moisture Plus fashion line of lip balm," Zendaya said. "Lip care is an important part of my daily beauty regimen, so it’s fun to have a lip balm that fits my style."  

The limited-edition Carmex Moisture Plus lip balm line has a fashion-forward exterior and combines the moisturizing formula of Carmex with broad spectrum SPF 15 sunscreen. Created to help keep lips healthy, protected and glamorous, the line appeals to an array of personal styles with personalities to match, including Chic in houndstooth, Fab in a pink plaid, Adventurous in leopard print and Starlet in a metallic chevron.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES